About Impedimed
Impedimed is a company based in Carlsbad (United States) founded in 1999.. Impedimed has raised $3.44 million across 8 funding rounds from investors including Versant Ventures and Starfish Ventures. The company has 77 employees as of June 30, 2025. Impedimed offers products and services including SOZO Digital Health Platform, L-Dex Analysis, and BodyComp Analysis. Impedimed operates in a competitive market with competitors including Bruker, Metrohm, Rigaku, Speclipse and Anvajo, among others.
- Headquarter Carlsbad, United States
- Employees 77 as on 30 Jun, 2025
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Impedimed Limited
-
Annual Revenue
$8.4 M (USD)23.31as on Jun 30, 2025
-
Net Profit
$-15.36 M (USD)-17.42as on Jun 30, 2025
-
EBITDA
$-12.98 M (USD)9.56as on Jun 30, 2025
-
Total Equity Funding
$3.44 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
Versant Ventures
& 1 more
-
Employee Count
77
as on Jun 30, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Impedimed
Impedimed is a publicly listed company on the ASX with ticker symbol IPD in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Impedimed
Impedimed offers a comprehensive portfolio of products and services, including SOZO Digital Health Platform, L-Dex Analysis, and BodyComp Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for bioimpedance spectroscopy to assess lymphedema early
Tool for monitoring lymphedema in cancer patients accurately
Analysis for segmental body composition in health assessments
Unlock access to complete
Unlock access to complete
Funding Insights of Impedimed
Impedimed has successfully raised a total of $3.44M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(08 Aug 2006)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2021 | Amount | Post-IPO - Impedimed | Valuation |
investors |
|
| Mar, 2016 | Amount | Post-IPO - Impedimed | Valuation |
investors |
|
| Mar, 2014 | Amount | Post-IPO - Impedimed | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Impedimed
Impedimed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Versant Ventures and Starfish Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Stage-agnostic sector-agnostic VC firm investing in Australia, New Zealand and the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Impedimed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Impedimed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Impedimed Comparisons
Competitors of Impedimed
Impedimed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bruker, Metrohm, Rigaku, Speclipse and Anvajo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diversified research instrument systems are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Instruments for chemical analysis are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
|
| domain | founded_year | HQ Location |
Molecular spectroscopy systems for early skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care solutions for laboratory diagnostics are provided by Anvajo.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Impedimed
Frequently Asked Questions about Impedimed
When was Impedimed founded?
Impedimed was founded in 1999 and raised its 1st funding round 7 years after it was founded.
Where is Impedimed located?
Impedimed is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Who is the current CEO of Impedimed?
Rick Valencia is the current CEO of Impedimed.
Is Impedimed a funded company?
Impedimed is a funded company, having raised a total of $3.44M across 8 funding rounds to date. The company's 1st funding round was a Post-IPO of $10.31M, raised on Aug 08, 2006.
How many employees does Impedimed have?
As of Jun 30, 2025, the latest employee count at Impedimed is 77.
What is the annual revenue of Impedimed?
Annual revenue of Impedimed is $8.4M as on Jun 30, 2025.
What does Impedimed do?
Impedimed was founded in 1999 and is headquartered in Carlsbad, United States. Non-invasive medical devices are developed by the company for clinical assessment and monitoring of fluid status. These devices support surgeons, oncologists, therapists, and radiation oncologists in evaluating patients for secondary lymphoedema. Operations focus on the health technology sector, with products designed for use in oncology and related therapeutic settings.
Who are the top competitors of Impedimed?
What products or services does Impedimed offer?
Impedimed offers SOZO Digital Health Platform, L-Dex Analysis, and BodyComp Analysis.
Is Impedimed publicly traded?
Yes, Impedimed is publicly traded on ASX under the ticker symbol IPD.
Who are Impedimed's investors?
Impedimed has 2 investors. Key investors include Versant Ventures, and Starfish Ventures.
What is Impedimed's ticker symbol?
The ticker symbol of Impedimed is IPD on ASX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.